Opportunity Information: Apply for PAR 21 175

Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R01 Clinical Trial Optional) is an NIH R01 grant opportunity (PAR-21-175; CFDA 93.242) focused on a very specific question in systems and translational neuroscience: if you deliberately change the timing patterns of coordinated brain activity, can you reliably improve cognition, emotion-related functioning, or social processing in living organisms. The emphasis is not just on observing neural rhythms, but on intervening in them in vivo, using a clear, testable rationale for why a particular electrophysiological pattern matters for a particular function.

The core scientific aim is to support projects that move beyond correlation and directly test causality. Applicants are encouraged to design studies in animals and/or humans that modify electrophysiological activity patterns such as oscillations, synchrony, coherence, phase relationships, cross-frequency coupling, or other temporal coordination features across neural populations and brain regions. A central expectation is that proposed interventions are grounded in a rational model of how these temporal dynamics help the brain route information, coordinate communication across circuits, or gate how incoming signals influence local computation. In practical terms, strong applications will typically connect a specific neural rhythm or coordination pattern to a mechanistic theory of information flow or circuit function, then show how an intervention that shifts that pattern should lead to measurable changes in cognitive performance, affective regulation, or social behavior.

Because the FOA is “clinical trial optional,” it can support both non-clinical and clinical work. Projects may include clinical trials if the research question and design meet NIH’s clinical trial definition, but a clinical trial is not required. That flexibility opens the door to a wide range of approaches, including animal studies using invasive recordings and perturbations, human studies using noninvasive recording and neuromodulation, or hybrid translational pipelines where an animal mechanistic discovery is used to justify a targeted human intervention study. The announcement also notes that a companion R21 is expected, signaling that NIH is likely supporting both shorter, exploratory/high-risk efforts (R21) and larger, more definitive hypothesis-driven programs (R01), with this R01 intended for projects that are ready for deeper mechanistic testing and stronger outcome validation.

In terms of fit, the FOA is aimed at research that actually modifies coordinated neural activity rather than simply measuring it. That can include a wide variety of electrophysiology-linked strategies, as long as the proposal clearly explains (1) what temporal dynamic is being targeted, (2) why that dynamic is functionally important for the domain being tested (cognitive, affective, or social), (3) how it will be modified, and (4) what outcomes will demonstrate improvement. Typical outcome measures could include behavioral performance metrics, symptom-relevant readouts, or task-based indices of cognitive control, learning, memory, emotion processing, or social interaction, paired with neural evidence that the intended electrophysiological pattern was actually changed in the predicted direction.

Eligibility is broad and includes many organization types beyond traditional research universities. Eligible applicants listed include state, county, city/township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofits (with or without 501(c)(3) status); for-profit organizations (other than small businesses) as well as small businesses; and other categories. The FOA explicitly highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISI institutions, Hispanic-serving institutions, HBCUs, tribally controlled colleges and universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and even non-U.S. (foreign) organizations. This breadth signals an intent to encourage participation from diverse institutional settings and communities, including those historically underrepresented in biomedical research funding.

Administratively, the opportunity is categorized as a discretionary grant mechanism under NIH, with an original closing date of January 7, 2025, and a creation date of March 18, 2021. The listing does not provide an award ceiling or expected number of awards in the supplied source text, which typically means applicants should consult the full FOA and NIH institute/center participation details for budget expectations, project period norms, and any institute-specific priorities or limits.

Overall, this FOA is designed for investigators who can connect circuit-level timing mechanisms to functional outcomes and who are prepared to test whether targeted manipulation of coordinated neural activity can produce meaningful improvements in cognition, affect, or social function. The best-aligned proposals will look like a tight loop between theory, measurement, intervention, and validated outcomes: identify a temporal coordination feature that plausibly drives a functional bottleneck, change it using a well-justified method, confirm that the neural dynamic changed as intended, and demonstrate that this change leads to improved processing in the domain of interest.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R01 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242.
  • This funding opportunity was created on 2021-03-18.
  • Applicants must submit their applications by 2025-01-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 21 175

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: FY 2021 Request for Concept Notes for NGO Programs Preventing, Preparing for, and Responding to COVID-19

Previous opportunity: Community Food Projects Competitive Grant Program

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 21 175

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 21 175) also looked into and applied for these:

Funding Opportunity
Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R21 Clinical Trial Optional) Apply for PAR 21 176

Funding Number: PAR 21 176
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Core Centers for Clinical Research (CCCR) (P30)- Clinical Trial Not Allowed Apply for RFA AR 22 002

Funding Number: RFA AR 22 002
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Short Courses on Interdisciplinary Behavioral and Social Sciences Research on Alzheimer's Disease and Related Dementias (R25 - Clinical Trial Not Allowed) Apply for RFA AG 22 010

Funding Number: RFA AG 22 010
Agency: National Institutes of Health
Category: Health
Funding Amount: $139,000
Short Courses on Interdisciplinary Behavioral and Social Sciences Research on Aging (R25 - Clinical Trial Not Allowed) Apply for RFA AG 22 009

Funding Number: RFA AG 22 009
Agency: National Institutes of Health
Category: Health
Funding Amount: $139,000
Limited Competition: Alzheimers Disease Sequencing Project Follow-Up Study 2.0 (ADSP FUS 2.0): The Diverse Population Initiative (U01 Clinical Trial Not Allowed) Apply for PAR 21 212

Funding Number: PAR 21 212
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Neural Mechanisms of Force-Based Manipulations: High Priority Research Networks (U24 Clinical Trial Optional) Apply for RFA AT 21 006

Funding Number: RFA AT 21 006
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NHGRI Predoctoral to Postdoctoral Transition Award for a Diverse Genomics Workforce (F99/K00) Apply for PAR 21 143

Funding Number: PAR 21 143
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Transformative Research to Address Health Disparities and Advance Health Equity at Minority Serving Institutions (U01 Clinical Trial Allowed) Apply for RFA RM 21 022

Funding Number: RFA RM 21 022
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Allowed) Apply for RFA RM 21 021

Funding Number: RFA RM 21 021
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R21 Clinical Trial Not Allowed) Apply for RFA HG 21 007

Funding Number: RFA HG 21 007
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Mechanisms of HIV Resistance to Broadly Neutralizing Antibodies (bNAbs) (U01 Clinical Trial Not Allowed) Apply for RFA AI 21 009

Funding Number: RFA AI 21 009
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R01 Clinical Trial Not Allowed) Apply for RFA HG 21 006

Funding Number: RFA HG 21 006
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R43/R44) Apply for RFA HG 21 008

Funding Number: RFA HG 21 008
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Understanding Post-Transcriptional Regulation of Intact and Defective HIV RNA (R61/R33 Clinical Trial Not Allowed) Apply for RFA AI 21 012

Funding Number: RFA AI 21 012
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIDCD's Mentoring Networks to Enhance Clinician-Scientists' Participation in Research (R25 Clinical Trial Not Allowed) Apply for PAR 21 187

Funding Number: PAR 21 187
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Technology and Analytic Cores (TACs) and Research Management Unit (RMU) (UC2 Clinical Trial Not Allowed) Apply for RFA AR 21 016

Funding Number: RFA AR 21 016
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Disease Teams for Rheumatoid Arthritis, Lupus, Psoriatic Spectrum Diseases, and Sjgrens Syndrome (UC2 Clinical Trial Optional) Apply for RFA AR 21 015

Funding Number: RFA AR 21 015
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required) Apply for PAR 21 210

Funding Number: PAR 21 210
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R34 Clinical Trial Required) Apply for PAR 21 211

Funding Number: PAR 21 211
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Innovative Programs to Enhance Research Training (IPERT) (R25 Independent Clinical Trial Not Allowed) Apply for PAR 21 196

Funding Number: PAR 21 196
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 21 175", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: